KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer

about

The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

P2860

Q48320749-09775B03-35FA-49F8-88E2-54D936DFE5E9 Q58695249-F943D758-77D9-4CF9-9C78-6F79D10DAF6A

P2860

KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer

Item

http://www.wikidata.org/entity/Q36362489

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@ast

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@en

type

Item

label

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@ast

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@en

prefLabel

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@ast

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@en

P1476

KRAS mutation analysis of sing ...... h metastatic colorectal cancer

@en

P2093

Hiroshi Hayashi

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Hayashi

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Kawakami

http://www.w3.org/2001/XMLSchema#string

Masakazu Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yukari Miwa

http://www.w3.org/2001/XMLSchema#string

P2860

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Intra-tumour heterogeneity: a looking glass for cancer?

An automated system for high-throughput single cell-based breeding.

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

P2888

s12885-017-3305-6

P304

311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3305-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuurin Kondo

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084956877

http://www.w3.org/2001/XMLSchema#string

P698

28468669

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5415811

http://www.w3.org/2001/XMLSchema#string

KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer

about

P2860

P2860

KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932